首页 > 市场调查报告书 > 製药

眼科药物

市场调查报告书

商品编码

1741414

结膜炎市场按疾病类型、给药途径、药物类别、分销管道和地区划分

Eye Flu (Conjunctivitis) Market, By Disease Type, By Route of Administration, By Drug Class, By Distribution Channel, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

结膜炎市场规模预计在 2025 年达到 52.9 亿美元，预计到 2032 年将达到 90.7 亿美元，2025 年至 2032 年的复合年增长率为 8%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	52.9亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	8.00%	2032年价值预测	90.7亿美元

结膜炎是一种常见的眼部感染疾病，影响全球数百万人。其特征是结膜（覆盖眼白并衬于眼睑内壁的薄而透明的膜）发炎。结膜炎可由多种因素引起，包括病毒或细菌感染、过敏和刺激物。

全球结膜炎市场竞争激烈，几家主要企业占据主导地位。诺华公司、艾尔建公司、博士伦製药、参天製药、强生公司、Alembic Pharmaceuticals 等是该市场的主要企业。这些公司提供广泛的产品和治疗方法，包括眼药水、药膏和口服药物。

市场动态：

全球结膜炎市场的成长受到多种因素的推动，例如眼部感染疾病盛行率的上升、眼部健康意识的增强以及医疗技术的进步。老年人口的增加、过敏和刺激物发病率的上升也促进了市场的成长。

然而，有几个因素阻碍了全球结膜炎市场的成长，例如治疗费用高、发展中地区医疗设施有限、替代疗法的可用性等。它还面临严格的监管要求和某些药物的副作用风险等挑战。

儘管面临诸多挑战，全球结膜炎市场仍蕴藏着巨大的成长机会。对有效安全治疗方法的需求不断增长、创新产品的开发以及新兴经济体医疗基础设施的不断扩展，预计将在不久的将来推动市场成长。

本研究的主要特点

本报告对全球结膜炎市场进行了详细分析，包括预测期为 2025 年至 2032 年的市场规模和复合年增长率（以 2024 年为基准年）。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
本报告的见解将使企业负责人和经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
全球结膜炎市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球结膜炎市场的各种策略矩阵更轻鬆地做出决策。

Novartis AG
Allergan
Bausch Health
Santen Pharmaceutical
Johnson & Johnson
Alembic Pharmaceuticals
Akorn Pharmaceuticals
Alcon
Pfizer
Valeant Pharmaceuticals
Merck & Co.
Similasan Corporation
Sun Pharmaceutical Industries
Prestige Consumer Healthcare
Lupin Pharmaceuticals
Alembic Pharmaceuticals
Aurolab
Intas Pharmaceuticals
Sun Pharma
Cipla

第 11 章章节

调查方法
关于出版商

简介目录

Product Code: CMI6211

Eye Flu (Conjunctivitis) Market is estimated to be valued at USD 5.29 Bn in 2025 and is expected to reach USD 9.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.29 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.00%	2032 Value Projection:	USD 9.07 Bn

Eye flu, also known as conjunctivitis, is a common eye infection that affects millions of people worldwide. It is characterized by inflammation of the conjunctiva, the thin, transparent layer that covers the white part of the eye and lines the inner surface of the eyelids. This condition can be caused by various factors including viral or bacterial infections, allergies, or irritants.

Global eye flu (conjunctivitis) market is highly competitive, with several key players dominating the industry. Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, and Alembic Pharmaceuticals are some of the leading companies in this market. These companies offer a wide range of products and treatments for eye flu including eye drops, ointments, and oral medications.

Market Dynamics:

Global eye flu (conjunctivitis) market growth is driven by several factors including the increasing prevalence of eye infections, growing awareness about eye health, and advancements in medical technology. Rising geriatric population and increasing incidence of allergies and irritants also contributes to the market growth.

However, there are certain restraints that may hinder growth of the global eye flu (conjunctivitis) market. These include the high cost of treatment, limited access to healthcare facilities in developing regions, and the availability of alternative treatments. The market faces challenges such as stringent regulatory requirements and the risk of adverse effects associated with certain medications.

Despite these challenges, the global eye flu (conjunctivitis) market presents numerous opportunities for growth. Increasing demand for effective and safe treatments, the development of innovative products, and the expansion of healthcare infrastructure in emerging economies are expected to drive the market growth in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global eye flu (conjunctivitis) market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, Alembic Pharmaceuticals, Akorn Pharmaceuticals, Alcon, Pfizer, Valeant Pharmaceuticals, Merck & Co., Similasan Corporation, Sun Pharmaceutical Industries, Prestige Consumer Healthcare, Lupin Pharmaceuticals, Alembic Pharmaceuticals, Aurolab, Intas Pharmaceuticals, Sun Pharma, and Cipla
Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global eye flu (conjunctivitis) market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye flu (conjunctivitis) market

Detailed Segmentation:

By Disease Type
- Viral Conjunctivitis
- Bacterial Conjunctivitis
- Allergic Conjunctivitis
- Chemical Conjunctivitis
- Others
By Route of Administration
- Topical
- Oral
- Intravenous
By Drug Class
- Antibiotics
- Anti-allergy
- Anti-inflammatories
- Combination
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Allergan
- Bausch Health
- Santen Pharmaceutical
- Johnson & Johnson
- Alembic Pharmaceuticals
- Akorn Pharmaceuticals
- Alcon
- Pfizer
- Valeant Pharmaceuticals
- Merck & Co.
- Similasan Corporation
- Sun Pharmaceutical Industries
- Prestige Consumer Healthcare
- Lupin Pharmaceuticals
- Alembic Pharmaceuticals
- Aurolab
- Intas Pharmaceuticals
- Sun Pharma
- Cipla

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Disease Type
- Market Snippet, By Route of Administration
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Eye Flu (Conjunctivitis) Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Eye Flu (Conjunctivitis) Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Viral Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Bacterial Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Chemical Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Eye Flu (Conjunctivitis) Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Eye Flu (Conjunctivitis) Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Anti-allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Eye Flu (Conjunctivitis) Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Eye Flu (Conjunctivitis) Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allergan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bausch Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Santen Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Alembic Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Akorn Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Alcon
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Valeant Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Similasan Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Prestige Consumer Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Alembic Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aurolab
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Intas Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cipla
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

结膜炎市场按疾病类型、给药途径、药物类别、分销管道和地区划分